22 results on '"CAMPOS, S."'
Search Results
2. The use of bevacizumab and concurrent radiation for recurrent gynecologic cancers.
3. Patterns of recurrence in advanced epithelial ovarian, fallopian tube, and peritoneal cancers treated with intraperitoneal chemotherapy.
4. Associations between age and quality of life in advanced ovarian cancer.
5. Sequential angiogenic blockade for the treatment of recurrent ovarian cancer.
6. Identification of localized rectal cancer (RC) patients (pts) who may not require preoperative (preop) chemoradiation (CRT).
7. Predictive value of circulating tumor cells for response to therapy in women with recurrent epithelial ovarian cancer.
8. Anaphylactic and anaphylactoid reactions to chemotherapy: outcomes and safety of rapid intravenous and intraperitoneal desensitizations in 413 cases
9. Comparison of the quality of life of early and advanced stage ovarian cancer survivors
10. Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer
11. Safety of maintenance bevacizumab after first-line chemotherapy for advanced ovarian and müllerian cancers
12. Chemotherapy and radiation therapy in UPSC
13. Phase II study of carboplatin, paclitaxel and bevacizumab as first line chemotherapy and consolidation for advanced müllerian tumors
14. Phase I trial of liposomal doxorubicin and ZD 1839 in patients with refractory gynecological malignancies or metastatic breast cancer
15. A phase II trial of modified triple doublets for the treatment of advanced Müllerian malignancies
16. Activity of oral irinotecan (IRI) in metastatic breast cancer (MBC) patients after prior anthracycline, taxane and capecitabine: Phase 2 study results
17. Rapid inpatient and outpatient desensitization for carboplatin or paclitaxel hypersensitivity: A protocol effective in patients with gynecologic malignancies
18. Long-acting octreotide for the treatment of symptoms of bowel obstruction in advanced ovarian cancer
19. A comparative study of exemestane versus anastrozole in post-menopausal breast cancer subjects with visceral disease
20. A phase II study of fixed dose-rate gemcitabine in patients with relapsed Müllerian tumors
21. A phase 2, single agent study of CI-1033 administered at two doses in ovarian cancer patients who failed platinum therapy
22. Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.